Anti-vascular endothelial growth factor for neovascular age-related macular degeneration in 2022: same, same but different

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	270-273
Number of pages	4
Journal	Clinical and Experimental Ophthalmology
Volume	50
Issue number	3
Early online date	16 Feb 2022
DOIs	https://doi.org/10.1111/ceo.14057
Publication status	Published - Apr 2022

Access to Document

@article{fbea13acb27c439c946629ddfda8739a,

title = "Anti-vascular endothelial growth factor for neovascular age-related macular degeneration in 2022: same, same but different",

author = "Fung, {Adrian T.}",

year = "2022",

month = apr,

doi = "10.1111/ceo.14057",

language = "English",

volume = "50",

pages = "270--273",

journal = "Clinical and Experimental Ophthalmology",

issn = "1442-6404",

publisher = "Wiley-Blackwell, Wiley",

number = "3",

}

TY - JOUR

T1 - Anti-vascular endothelial growth factor for neovascular age-related macular degeneration in 2022

T2 - same, same but different

AU - Fung, Adrian T.

PY - 2022/4

Y1 - 2022/4

UR - http://www.scopus.com/inward/record.url?scp=85124745545&partnerID=8YFLogxK

U2 - 10.1111/ceo.14057

DO - 10.1111/ceo.14057

M3 - Editorial

C2 - 35174600

AN - SCOPUS:85124745545

SN - 1442-6404

VL - 50

SP - 270

EP - 273

JO - Clinical and Experimental Ophthalmology

JF - Clinical and Experimental Ophthalmology

IS - 3

ER -